News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
The third country worldwide to approve this medication for HCC in combination with Durvalumab – Prof.Humaid Al-Shamsi
Photo: Prof.Humaid Al-Shamsi/Linkedin
Jun 12, 2023, 03:13

The third country worldwide to approve this medication for HCC in combination with Durvalumab – Prof.Humaid Al-Shamsi

Last night in Dubai , in collaboration with AstraZeneca we successfully launched tremelimumab for the treatment of hepatocellular carcinoma (HCC). This remarkable achievement makes us the third country worldwide to approve this medication for HCC in combination with Durvalumab. Our unwavering commitment to providing the most advanced treatments for our patients in the UAE and the region remains steadfast.

Source: Prof.Humaid Al-Shamsi/Linkedin

AstraZeneca Durvalumab HCC Humaid Al-Shamsi Tremelimumab
Special Coverage
Oncolibrary
Mar 13, 2025, 15:52
New Paper Alert: Management of Immune Checkpoint Inhibitor-Associated Toxicities in Older Adults with Cancer
Blog
Mar 13, 2025, 14:28
Judy Medeiros Fitzgerald: Why cancer patients dislike labels like "survivor" and "warrior"
Blog
Mar 13, 2025, 14:26
Join EORTC in Brussels as a Clinical Research Associate
Blog
Mar 13, 2025, 11:07
Yan Leyfman: Phenomenal Grand Rounds by Global Cell Therapy Leader - Katy Rezvani
Blog
Mar 13, 2025, 10:43
Eric Bouffet about My Child Matters project - Foundation S
Blog
Mar 13, 2025, 10:14
Miriam Mutebi: Breast cancer is a growing crisis in Africa
Blog
Mar 13, 2025, 10:06
The Call for Abstract for IUCS25 is open - International Urology Cancer Summit
Science
Mar 13, 2025, 09:32
Myeloma Paper of the Day, March 13th, suggested by Robert Orlowski
Science
Mar 13, 2025, 09:10
George Vlachogiannis: Radical surgery vs RTH for sacral chordoma treatment
Blog
Mar 13, 2025, 09:07
Translating Genomic Discoveries into Therapies with Triparna Sen - GRACE
Blog
Mar 13, 2025, 08:55
The Improving Care of EBC Patients in Europe Investigators Meeting - SPCC
Blog
Mar 13, 2025, 08:44
RORγ bridges cancer-driven lipid dysmetabolism and myeloid immunosuppression